目的:系统评价网络化认知行为疗法(ICBT)对癌症病人负性情绪和生活质量的干预效果。方法:通过计算机检索the Cochrane Library、PubMed、EMbase、Web of Science、ScienceDirect、中国生物医学文献数据库、中国知网、万方数据库及维普...目的:系统评价网络化认知行为疗法(ICBT)对癌症病人负性情绪和生活质量的干预效果。方法:通过计算机检索the Cochrane Library、PubMed、EMbase、Web of Science、ScienceDirect、中国生物医学文献数据库、中国知网、万方数据库及维普数据库等数据库,收集关于ICBT应用于癌症病人的随机对照研究,检索时间为建库到2021年9月1日。两名研究者筛选文献,并进行提取资料和质量评价。使用RevMan 5.4软件对纳入文献进行Meta分析。结果:最终纳入10篇文献,包括1278例癌症病人。研究结果显示,ICBT可以改善癌症病人的焦虑情绪[SMD=-2.19,95%CI(-3.35,-1.03),P=0.0002]、抑郁情绪[SMD=-1.85,95%CI(-2.90,-0.80),P=0.0005]、癌症复发恐惧[MD=-3.48,95%CI(-3.26,-3.33),P<0.0001]和生活质量[SMD=1.25,95%CI(0.52,1.99),P=0.0009]。结论:现有证据表明,ICBT能减轻癌症病人的焦虑、抑郁和癌症复发恐惧情绪,提高生活质量。展开更多
Aim: To analyse and assess the effect of dose rate of 192ir-source strength on late complications and local control rate during treatment of carcinoma cervix. Materials and Methods: One hundred and two cases of carcin...Aim: To analyse and assess the effect of dose rate of 192ir-source strength on late complications and local control rate during treatment of carcinoma cervix. Materials and Methods: One hundred and two cases of carcinoma cervix were included in the study. All patients were treated with a curative intent with radical dose of radiation as per the department protocol. All patients were treated with both EBRT plus Brachytherapy with Inj. Cisplatin 40 mg/m2 weekly. Patients were divided into 2 groups based on activity i.e. group A (10-6Ci) and group B (5-2Ci). After brachytherapy, point doses were analysed based on ICRU 38 recommendations. During follow up, morbidities were evaluated using RTOG grading system. Results: There was no difference in local control and distant metastasis in both groups after six months of follow up. Late Complications were comparable in both groups irrespective of source strength. Bladder complications were minimal with no significant difference in both study groups. Further Patients were divided into four groups i.e. BED of ICRU rectal point (3 and ≥100 Gy3) and source strength (10-6Ci and 5-2Ci), when BED was >100 Gy3 resulted in higher late rectal complication rate (P 3. Conclusion: This study suggests that change in source activity did not make a difference in local control, late rectal and bladder morbidities at 6 months of follow up. Longer follow up is required to assess long term results and morbidities.展开更多
文摘Aim: To analyse and assess the effect of dose rate of 192ir-source strength on late complications and local control rate during treatment of carcinoma cervix. Materials and Methods: One hundred and two cases of carcinoma cervix were included in the study. All patients were treated with a curative intent with radical dose of radiation as per the department protocol. All patients were treated with both EBRT plus Brachytherapy with Inj. Cisplatin 40 mg/m2 weekly. Patients were divided into 2 groups based on activity i.e. group A (10-6Ci) and group B (5-2Ci). After brachytherapy, point doses were analysed based on ICRU 38 recommendations. During follow up, morbidities were evaluated using RTOG grading system. Results: There was no difference in local control and distant metastasis in both groups after six months of follow up. Late Complications were comparable in both groups irrespective of source strength. Bladder complications were minimal with no significant difference in both study groups. Further Patients were divided into four groups i.e. BED of ICRU rectal point (3 and ≥100 Gy3) and source strength (10-6Ci and 5-2Ci), when BED was >100 Gy3 resulted in higher late rectal complication rate (P 3. Conclusion: This study suggests that change in source activity did not make a difference in local control, late rectal and bladder morbidities at 6 months of follow up. Longer follow up is required to assess long term results and morbidities.
